vTv Therapeutics Announces Investment by CinRx Pharma
vTv Therapeutics Inc. today announced entry into agreements that include a $10 million investment by CinPax, LLC (“CinPax”), a subsidiary of CinRx Pharma, LLC (“CinRx”).
CinDome Pharma announces successful completion of thorough QT study of CIN- 102
CinDome Pharma announced the negative results of a clinical thorough QT/QTc study of CIN-102.
CinDome Pharma Announces Start of Phase 2 Trial of Deuterated Domperidone (CIN-102)
CinDome Pharma Announces Start of Phase 2 Trial of Deuterated Domperidone (CIN-102).